US Stock MarketDetailed Quotes

Tonix Pharmaceuticals (TNXP)

Watchlist
  • 13.980
  • -0.150-1.06%
Close Apr 17 16:00 ET
  • 13.950
  • -0.030-0.21%
Post 19:42 ET
198.59MMarket Cap-0.96P/E (TTM)

Tonix Pharmaceuticals (TNXP) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-63.88%-99.84M
-171.02%-39.65M
-53.09%-28.78M
-49.54%-14.83M
5.67%-16.58M
40.27%-60.93M
34.51%-14.63M
19.60%-18.8M
57.55%-9.92M
46.60%-17.58M
Net income from continuing operations
4.63%-124.02M
-112.19%-46.91M
-125.22%-32.01M
64.11%-28.27M
-12.65%-16.83M
-11.47%-130.04M
19.08%-22.11M
49.19%-14.21M
-177.81%-78.78M
54.74%-14.94M
Operating gains losses
134.02%2.09M
--0
--0
--0
129.86%2.09M
-2,882.81%-6.15M
--0
--0
--855K
---7.01M
Depreciation and amortization
-43.73%1.93M
-1.61%488K
-9.61%461K
-59.92%483K
-59.26%493K
-20.27%3.42M
-60.67%496K
-58.06%510K
30.84%1.21M
35.50%1.21M
Other non cash items
483.10%4.9M
818.50%1.84M
454.55%1.16M
1,324.03%1.84M
-78.48%65K
-6.98%840K
--200K
--209K
--129K
--302K
Change In working capital
47.97%8.55M
-40.85%3.8M
109.30%616K
53.89%7.42M
-381.72%-3.28M
16,600.00%5.78M
1,667.49%6.42M
-544.33%-6.63M
182.81%4.82M
132.42%1.17M
-Change in receivables
28.89%-2.62M
-314.70%-2.79M
27.39%-1.19M
129.71%992K
--371K
---3.68M
-16.84%1.3M
-5.19%-1.64M
---3.34M
--0
-Change in inventory
-53.86%1.73M
628.00%364K
-2.17%1.22M
-111.25%-130K
-78.88%272K
6,032.79%3.74M
-18.03%50K
--1.25M
--1.16M
--1.29M
-Change in prepaid assets
-187.49%-3.16M
-134.05%-1M
-391.50%-1.68M
-94.34%134K
54.46%-617K
129.69%3.61M
267.12%2.94M
-111.12%-341K
60.52%2.37M
-12.35%-1.36M
-Change in payables and accrued expense
509.45%12.9M
252.61%7.51M
138.61%2.27M
38.51%6.43M
-368.54%-3.3M
224.24%2.12M
334.49%2.13M
-19,506.67%-5.88M
2,028.44%4.64M
151.64%1.23M
-Change in other current liabilities
-2,230.77%-303K
----
----
----
----
-137.14%-13K
----
----
----
----
-Change in other working capital
----
----
0.00%-6K
-75.00%-7K
-350.00%-5K
----
----
-135.29%-6K
-133.33%-4K
140.00%2K
Cash from discontinued investing activities
Operating cash flow
-63.88%-99.84M
-171.02%-39.65M
-53.09%-28.78M
-49.54%-14.83M
5.67%-16.58M
40.27%-60.93M
34.51%-14.63M
19.60%-18.8M
57.55%-9.92M
46.60%-17.58M
Investing cash flow
Cash flow from continuing investing activities
-3,673.33%-4.53M
-33,933.33%-1.02M
-10,588.89%-962K
-2.54M
94.44%-6K
99.59%-120K
99.30%-3K
98.90%-9K
0
97.16%-108K
Net PPE purchase and sale
-2,707.50%-3.37M
-62,366.67%-1.87M
-10,588.89%-962K
---527K
94.44%-6K
98.26%-120K
99.30%-3K
98.90%-9K
--0
97.16%-108K
Net business purchase and sale
----
----
----
----
----
--0
--0
--0
----
----
Net other investing changes
---1.16M
--853K
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-3,673.33%-4.53M
-33,933.33%-1.02M
-10,588.89%-962K
---2.54M
94.44%-6K
99.59%-120K
99.30%-3K
98.90%-9K
--0
97.16%-108K
Financing cash flow
Cash flow from continuing financing activities
59.06%214.53M
-30.55%59.14M
121.10%94.86M
56.48%10.99M
23,464.62%49.53M
269.34%134.87M
109.15%85.15M
583.85%42.91M
582.70%7.03M
98.16%-212K
Net issuance payments of debt
-310.64%-9.65M
--0
--0
--0
-4,006.38%-9.65M
-126.28%-2.35M
-107.88%-705K
---705K
---705K
---235K
Net common stock issuance
59.91%224.18M
-31.12%59.14M
117.54%94.86M
2.45%10.99M
--59.18M
2,718.56%140.2M
833.25%85.86M
595.03%43.61M
942.76%10.73M
--0
Net preferred stock issuance
----
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
--0
--0
--0
--0
--0
-6.90%27K
--0
--4K
--0
-20.69%23K
Net other financing activities
----
----
----
----
----
-113.29%-3M
--0
--0
----
----
Cash from discontinued financing activities
Financing cash flow
59.06%214.53M
-30.55%59.14M
121.10%94.86M
56.48%10.99M
23,464.62%49.53M
269.34%134.87M
109.15%85.15M
583.85%42.91M
582.70%7.03M
98.16%-212K
Net cash flow
Beginning cash position
285.62%99.68M
556.74%191.35M
2,395.77%126.24M
1,567.95%132.62M
285.61%99.68M
-78.54%25.85M
268.06%29.14M
-80.44%5.06M
-88.99%7.95M
-78.54%25.85M
Current changes in cash
49.21%110.16M
-73.81%18.47M
170.25%65.12M
-120.42%-6.38M
284.12%32.95M
178.08%73.83M
293.03%70.52M
234.37%24.1M
93.76%-2.89M
62.88%-17.9M
Effect of exchange rate changes
-875.00%-31K
-158.33%-14K
76.47%-4K
-500.00%-4K
-125.00%-9K
106.15%4K
340.00%24K
-41.67%-17K
--1K
90.70%-4K
End cash Position
110.48%209.81M
110.48%209.81M
556.74%191.35M
2,395.77%126.24M
1,567.95%132.62M
285.62%99.68M
285.62%99.68M
268.06%29.14M
-80.44%5.06M
-88.99%7.95M
Free cash flow
-69.08%-103.21M
-183.77%-41.52M
-47.43%-27.73M
-75.14%-17.37M
6.21%-16.59M
44.45%-61.05M
35.76%-14.63M
25.35%-18.81M
60.66%-9.92M
51.83%-17.68M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -63.88%-99.84M-171.02%-39.65M-53.09%-28.78M-49.54%-14.83M5.67%-16.58M40.27%-60.93M34.51%-14.63M19.60%-18.8M57.55%-9.92M46.60%-17.58M
Net income from continuing operations 4.63%-124.02M-112.19%-46.91M-125.22%-32.01M64.11%-28.27M-12.65%-16.83M-11.47%-130.04M19.08%-22.11M49.19%-14.21M-177.81%-78.78M54.74%-14.94M
Operating gains losses 134.02%2.09M--0--0--0129.86%2.09M-2,882.81%-6.15M--0--0--855K---7.01M
Depreciation and amortization -43.73%1.93M-1.61%488K-9.61%461K-59.92%483K-59.26%493K-20.27%3.42M-60.67%496K-58.06%510K30.84%1.21M35.50%1.21M
Other non cash items 483.10%4.9M818.50%1.84M454.55%1.16M1,324.03%1.84M-78.48%65K-6.98%840K--200K--209K--129K--302K
Change In working capital 47.97%8.55M-40.85%3.8M109.30%616K53.89%7.42M-381.72%-3.28M16,600.00%5.78M1,667.49%6.42M-544.33%-6.63M182.81%4.82M132.42%1.17M
-Change in receivables 28.89%-2.62M-314.70%-2.79M27.39%-1.19M129.71%992K--371K---3.68M-16.84%1.3M-5.19%-1.64M---3.34M--0
-Change in inventory -53.86%1.73M628.00%364K-2.17%1.22M-111.25%-130K-78.88%272K6,032.79%3.74M-18.03%50K--1.25M--1.16M--1.29M
-Change in prepaid assets -187.49%-3.16M-134.05%-1M-391.50%-1.68M-94.34%134K54.46%-617K129.69%3.61M267.12%2.94M-111.12%-341K60.52%2.37M-12.35%-1.36M
-Change in payables and accrued expense 509.45%12.9M252.61%7.51M138.61%2.27M38.51%6.43M-368.54%-3.3M224.24%2.12M334.49%2.13M-19,506.67%-5.88M2,028.44%4.64M151.64%1.23M
-Change in other current liabilities -2,230.77%-303K-----------------137.14%-13K----------------
-Change in other working capital --------0.00%-6K-75.00%-7K-350.00%-5K---------135.29%-6K-133.33%-4K140.00%2K
Cash from discontinued investing activities
Operating cash flow -63.88%-99.84M-171.02%-39.65M-53.09%-28.78M-49.54%-14.83M5.67%-16.58M40.27%-60.93M34.51%-14.63M19.60%-18.8M57.55%-9.92M46.60%-17.58M
Investing cash flow
Cash flow from continuing investing activities -3,673.33%-4.53M-33,933.33%-1.02M-10,588.89%-962K-2.54M94.44%-6K99.59%-120K99.30%-3K98.90%-9K097.16%-108K
Net PPE purchase and sale -2,707.50%-3.37M-62,366.67%-1.87M-10,588.89%-962K---527K94.44%-6K98.26%-120K99.30%-3K98.90%-9K--097.16%-108K
Net business purchase and sale ----------------------0--0--0--------
Net other investing changes ---1.16M--853K--------------------------------
Cash from discontinued investing activities
Investing cash flow -3,673.33%-4.53M-33,933.33%-1.02M-10,588.89%-962K---2.54M94.44%-6K99.59%-120K99.30%-3K98.90%-9K--097.16%-108K
Financing cash flow
Cash flow from continuing financing activities 59.06%214.53M-30.55%59.14M121.10%94.86M56.48%10.99M23,464.62%49.53M269.34%134.87M109.15%85.15M583.85%42.91M582.70%7.03M98.16%-212K
Net issuance payments of debt -310.64%-9.65M--0--0--0-4,006.38%-9.65M-126.28%-2.35M-107.88%-705K---705K---705K---235K
Net common stock issuance 59.91%224.18M-31.12%59.14M117.54%94.86M2.45%10.99M--59.18M2,718.56%140.2M833.25%85.86M595.03%43.61M942.76%10.73M--0
Net preferred stock issuance ----------------------0----------------
Proceeds from stock option exercised by employees --0--0--0--0--0-6.90%27K--0--4K--0-20.69%23K
Net other financing activities ---------------------113.29%-3M--0--0--------
Cash from discontinued financing activities
Financing cash flow 59.06%214.53M-30.55%59.14M121.10%94.86M56.48%10.99M23,464.62%49.53M269.34%134.87M109.15%85.15M583.85%42.91M582.70%7.03M98.16%-212K
Net cash flow
Beginning cash position 285.62%99.68M556.74%191.35M2,395.77%126.24M1,567.95%132.62M285.61%99.68M-78.54%25.85M268.06%29.14M-80.44%5.06M-88.99%7.95M-78.54%25.85M
Current changes in cash 49.21%110.16M-73.81%18.47M170.25%65.12M-120.42%-6.38M284.12%32.95M178.08%73.83M293.03%70.52M234.37%24.1M93.76%-2.89M62.88%-17.9M
Effect of exchange rate changes -875.00%-31K-158.33%-14K76.47%-4K-500.00%-4K-125.00%-9K106.15%4K340.00%24K-41.67%-17K--1K90.70%-4K
End cash Position 110.48%209.81M110.48%209.81M556.74%191.35M2,395.77%126.24M1,567.95%132.62M285.62%99.68M285.62%99.68M268.06%29.14M-80.44%5.06M-88.99%7.95M
Free cash flow -69.08%-103.21M-183.77%-41.52M-47.43%-27.73M-75.14%-17.37M6.21%-16.59M44.45%-61.05M35.76%-14.63M25.35%-18.81M60.66%-9.92M51.83%-17.68M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More